STAT3 and non-small cell lung carcinoma: Xu et al used a meta-analysis to quantitatively assess STAT3 and phospho-STAT3 expression on the prognosis of NSCLC and found that high STAT3 or phospho-STAT3 expression is a strong predictor of poor prognosis among patients with NSCLC [9].